Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers

Chest

Volumn 152, Issue 4, 2017, Pages 780-791

  Ash, Samuel Y ^a   Harmouche, Rola ^b   Putman, Rachel K ^a   Ross, James C ^b   Diaz, Alejandro A ^a   Hunninghake, Gary M ^a   Onieva Onieva, Jorge ^b   Martinez, Fernando J ^c   Choi, Augustine M ^c   Lynch, David A ^d   Hatabu, Hiroto ^b   Rosas, Ivan O ^a   San Jose Estepar, Raul ^b   Washko, George R ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d DEPARTMENT OF MEDICINE   (United States)

Author keywords

CT scanning; emphysema; interstitial lung abnormalities; mortality; pulmonary fibrosis

Indexed keywords

MUCIN 5B; DNA; MUC5B PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLACK PERSON; CAUCASIAN; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE DOSAGE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPING TECHNIQUE; HUMAN; IMAGE ANALYSIS; LUNG FUNCTION; MALE; MORTALITY RISK; MUC5B GENE; PRIORITY JOURNAL; PROMOTER REGION; QUALITY OF LIFE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; X-RAY COMPUTED TOMOGRAPHY; ADVERSE EFFECTS; ALLELE; CLINICAL TRIAL; GENETIC POLYMORPHISM; GENETICS; INCIDENCE; LUNG DISEASES, INTERSTITIAL; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; SPIROMETRY; SURVIVAL RATE; TRENDS; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALLELES; DNA; FEMALE; HUMANS; INCIDENCE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MUCIN-5B; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; QUALITY OF LIFE; SMOKING; SPIROMETRY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 85030696044     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2017.04.185     Document Type: Article

References (39)

1. Kirchner, J., Goltz, J.P., Lorenz, F., Obermann, A., Kirchner, E.M., Kickuth, R., The “dirty chest”: correlations between chest radiography, multislice CT and tobacco burden. Br J Radiol 85:1012 (2012), 339–345.
2. Reid, L., Simon, G., Pathological findings and radiological changes in chronic bronchitis and emphysema. Br J Radiol 32:377 (1959), 291–305.
3. Grubstein, A., Bendayan, D., Schactman, I., Cohen, M., Shitrit, D., Kramer, M.R., Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature. Respir Med 99:8 (2005), 948–954.
4. Kitaguchi, Y., Fujimoto, K., Hanaoka, M., Kawakami, S., Honda, T., Kubo, K., Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 15:2 (2010), 265–271.
5. Cottin, V., Cordier, J.F., The syndrome of combined pulmonary fibrosis and emphysema. Chest 136:1 (2009), 1–2.
6. Doyle, T.J., Hunninghake, G.M., Rosas, I.O., Subclinical interstitial lung disease: why you should care. Am J Respir Crit Care Med 185:11 (2012), 1147–1153.
7. Washko, G.R., Hunninghake, G.M., Fernandez, I.E., et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 364:10 (2011), 897–906.
8. Hunninghake, G.M., Hatabu, H., Okajima, Y., et al. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med 368:23 (2013), 2192–2200.
9. Putman, R.K., Rosas, I.O., Hunninghake, G.M., Genetics and early detection in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 189:7 (2014), 770–778.
10. Seibold, M.A., Wise, A.L., Speer, M.C., et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 364:16 (2011), 1503–1512.
11. Doyle, T.J., Washko, G.R., Fernandez, I.E., et al. Interstitial lung abnormalities and reduced exercise capacity. Am J Respir Crit Care Med 185:7 (2012), 756–762.
12. Putman, R.K., Hatabu, H., Araki, T., et al. Association between interstitial lung abnormalities and all-cause mortality. JAMA 315:7 (2016), 672–681.
13. Washko, G.R., Lynch, D.A., Matsuoka, S., et al. Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol 17:1 (2010), 48–53.
14. Castaldi, P.J., San Jose Estepar, R., Mendoza, C.S., et al. Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers. Am J Respir Crit Care Med 188:9 (2013), 1083–1090.
15. Ash SY, Harmouche R, Ross JC, et al. The objective identification and quantification of interstitial lung abnormalities in smokers [published online ahead of print December 15, 2016]. Acad Radiol. http://dx.doi.org/10.1016/j.acra.2016.08.023.
16. Regan, E.A., Hokanson, J.E., Murphy, J.R., et al. Genetic Epidemiology of COPD (COPDGene) study design. COPD 7:1 (2010), 32–43.
17. Jones, P.W., Quirk, F.H., Baveystock, C.M., The St George's Respiratory Questionnaire. Respir Med 85:suppl B (1991), 25–31.
18. Jones, P.W., Quirk, F.H., Baveystock, C.M., Littlejohns, P., A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 145:6 (1992), 1321–1327.
19. Schoenfeld, D., Partial residuals for the proportional hazards regression model. Biometrika 69:1 (1982), 239–241.
20. Woodruff, P.G., Barr, R.G., Bleecker, E., et al. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med 374:19 (2016), 1811–1821.
21. Stavem, K., Sandvik, L., Erikssen, J., Breathlessness, phlegm and mortality: 26 years of follow-up in healthy middle-aged Norwegian men. J Intern Med 260:4 (2006), 332–342.
22. Stavem, K., Sandvik, L., Erikssen, J., Can global initiative for chronic obstructive lung disease stage 0 provide prognostic information on long-term mortality in men?. Chest 130:2 (2006), 318–325.
23. Araki, T., Putman, R.K., Hatabu, H., et al. Development and progression of interstitial lung abnormalities in the Framingham Heart Study. Am J Respir Crit Care Med 194:12 (2016), 1514–1522.
24. Muller, N.L., Staples, C.A., Miller, R.R., Abboud, R.T., “Density mask”: an objective method to quantitate emphysema using computed tomography. Chest 94:4 (1988), 782–787.
25. Ash, S.Y., Washko, G.R., Controversies in COPD: the value of CT scanning. Eur Respir Soc Monogr 69 (2015), 121–133.
26. Coxson, H.O., Rogers, R.M., Whittall, K.P., et al. A quantification of the lung surface area in emphysema using computed tomography. Am J Respir Crit Care Med 159:3 (1999), 851–856.
27. Lederer, D.J., Enright, P.L., Kawut, S.M., et al. Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. Am J Respir Crit Care Med 180:5 (2009), 407–414.
28. Podolanczuk, A.J., Oelsner, E.C., Barr, R.G., et al. High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study. Eur Respir J 48:5 (2016), 1442–1452.
29. Bartholmai, B.J., Raghunath, S., Karwoski, R.A., et al. Quantitative computed tomography imaging of interstitial lung diseases. J Thorac Imaging 28:5 (2013), 298–307.
30. Iwasawa, T., Ogura, T., Sakai, F., et al. CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis. Eur J Radiol 83:1 (2014), 32–38.
31. Iwasawa, T., Asakura, A., Sakai, F., et al. Assessment of prognosis of patients with idiopathic pulmonary fibrosis by computer-aided analysis of CT images. J Thorac Imaging 24:3 (2009), 216–222.
32. Maldonado, F., Moua, T., Rajagopalan, S., et al. Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis. Eur Respir J 43:1 (2014), 204–212.
33. Peljto, A.L., Zhang, Y., Fingerlin, T.E., et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA 309:21 (2013), 2232–2239.
34. Beijers, R.J., van den Borst, B., Newman, A.B., et al. A multidimensional risk score to predict all-cause hospitalization in community-dwelling older individuals with obstructive lung disease. J Am Med Dir Assoc 17:6 (2016), 508–513.
35. McDonald, M.L., Diaz, A.A., Ross, J.C., et al. Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease: a cross-sectional study. Ann Am Thorac Soc 11:3 (2014), 326–334.
36. Martinez-Garcia, M.A., de la Rosa Carrillo, D., Soler-Cataluna, J.J., et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187:8 (2013), 823–831.
37. Verschuren, W.M., Jacobs, D.R., Bloemberg, B.P., et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures: twenty-five-year follow-up of the seven countries study. JAMA 274:2 (1995), 131–136.
38. Kim, H.J., Li, G., Gjertson, D., et al. Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study. Acad Radiol 15:8 (2008), 1004–1016.
39. Colom, M., Buades, A., Morel, J.M., Nonparametric noise estimation method for raw images. J Opt Soc Am A Opt Image Sci Vis 31:4 (2014), 863–871.